5-Day Preoperative Radiation for Soft Tissue Sarcoma

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorStanford University

About this trial

The purpose of this study is to examine the safety and efficacy of an abbreviated course of preoperative radiation, given over five days, for patients with soft tissue sarcoma of the extremity, trunk or retroperitoneum. This is in contrast to standard preoperative radiation, which is given over 25 days.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Histologically confirmed soft tissue sarcoma of the extremity, trunk or retroperitoneum.

Has been offered preoperative radiation and surgery as part of standard-of-care treatment

Age ≥ 18

KPS ≥ 70 or ECOG 0 to 2

Disqualifiers

History of prior radiation to the area to be treated.

Active use of other anti-cancer investigational agents.

Planned use of concurrent chemotherapy, targeted therapy, or immunotherapy with radiation therapy (defined as the time interval starting 1 week before the first and last fraction of radiation therapy and surgery).

Pregnancy.

Trial design

Design model

Single group

Treatments tested in this trial

  • External Beam Radiotherapy

    Radiation

    Radiation will be delivered by external beam techniques to the tumor and areas of possible microscopic disease at a dose of 30 Gy divided into 5 equal fractions of 6 Gy (administered over a total of 5 to 10 business day

Treatment groups

75 Participants
are divided into 1 treatment group
Group A: External beam radiotherapyExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Post-operative Complication Rate

Rate of post-operative complications.

Time frame
120 days after surgery

Secondary outcomes

1

Local Recurrence Rate

Rate of local recurrence, including in-field, borderline and out-field recurrences

Time frame
2 years and 5 years after surgical resection

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.